HMOX1 and myeloid sarcoma: We previously observed that peripheral blood mononuclear cells (PBMCs) from relapsing–remitting multiple sclerosis (RR MS) patients express less HMOX1 than PBMCs from healthy controls and that HMOX1 transcriptional levels are significantly downregulated during the acute exacerbation of the disease [4].